Mass General Hospital Cancer Center

Boston, Massachusetts 02114

0 studies enrolling now · 1 studies all time

What they study most

Waldenstrom's Macroglobulinemia

Studies at this site

• A Study of Mavorixafor in Combination With Ibrutinib in Participants With Waldenstrom's Macroglobulinemia (WM) Whose Tumors Express Mutations in MYD88 and CXCR4 — Completed